Why is Piramal Pharma falling/rising?

As of 23-Jul, Piramal Pharma Ltd's stock price is currently at 205.15, reflecting a decrease of 0.2, or 0.1%. The stock has underperformed its sector today by 0.61% and has experienced a consecutive decline over the last two days, resulting in a total drop of 3.09%. In the past week, the stock has fallen by 4.45%, while it has shown a positive return of 5.58% over the last month. Despite a strong annual performance with a return of 31.30%, the stock's year-to-date performance is down 22.82%. The company has reported healthy long-term growth, with operating profit increasing significantly, but it also faces challenges such as a high Debt to EBITDA ratio and low profitability per unit of shareholders' funds, which may be contributing to the recent price decline.
In the broader market context, the Sensex has shown a slight increase of 0.11% over the past week, contrasting with Piramal Pharma's negative performance. While the stock has outperformed the market over the past year, its recent struggles may be exacerbated by falling investor participation, as indicated by a 32.25% drop in delivery volume compared to the five-day average. The stock's liquidity remains adequate for trading, but the combination of declining short-term performance and concerns over debt servicing capabilities may be influencing investor sentiment negatively, leading to the current price movement.